Paul Volberding | Academic Influence

Paul Volberding's AcademicInfluence.com Rankings

Paul Volberding

Biology

#1699

World Rank

#2767

Historical Rank

#815

USA Rank

Immunology

#159

World Rank

#167

Historical Rank

#51

USA Rank

biology Degrees

Download Badge

Biology

Paul Volberding's Degrees

Doctorate Medicine University of Chicago
Masters Public Health University of California, Berkeley

Why Is Paul Volberding Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul A. Volberding is an American physician who is best known for his pioneering work in treating people with HIV. Work In 1983, Volberding founded the first inpatient ward for persons with AIDS in the San Francisco General Hospital. He worked on early clinical trials to evaluate antiretroviral therapy in HIV infection, and has served on the two major guidelines panels for antiretroviral therapy, addressing issues such as the optimal timing of treatment in early HIV infection when no symptoms are evident.

(See a Problem?)

Paul Volberding's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 (1998) (3678)
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. (1987) (2759)
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. (2008) (2385)
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. (1987) (1503)
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. (1997) (1316)
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. (2000) (1117)
Antiretroviral Treatment of Adult HIV Infection (2008) (1090)
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. (1998) (1006)
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. (1990) (1006)
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. (1984) (927)
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. (2004) (900)
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. (2008) (828)
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. (2002) (777)
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. (2006) (769)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. (2016) (753)
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. (2012) (742)
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. (2004) (730)
Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel (1996) (651)
HIV viral load markers in clinical practice (1996) (561)
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial (1990) (532)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel (2018) (527)
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) (476)
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. (1996) (451)
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. (2014) (435)
AIDS-associated non-Hodgkin's lymphoma in San Francisco. (1989) (420)
Antiretroviral therapy and management of HIV infection (2010) (401)
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma (1996) (373)
Panel on Clinical Practices for Treatment of HIV Infection (2000) (349)
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. (1992) (340)
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. (1986) (323)
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. (2004) (283)
B-cell immunodeficiency in acquired immune deficiency syndrome. (1984) (274)
Anemia in HIV infection: clinical impact and evidence-based management strategies. (2004) (262)
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. (1990) (255)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. (2020) (246)
CYTOMEGALOVIRUS AND KAPOSI'S SARCOMA IN YOUNG HOMOSEXUAL MEN (1982) (236)
Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. (1985) (228)
Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. (1991) (195)
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. (2002) (194)
Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex (1989) (193)
Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. (1986) (189)
CD4+ Lymphocytes Are an Incomplete Surrogate Marker for Clinical Progression in Persons with Asymptomatic HIV Infection Taking Zidovudine (1993) (185)
The Medical Management of AIDS (1988) (179)
Preferences of homosexual men with AIDS for life-sustaining treatment. (1986) (173)
Acquired immune dysfunction in homosexual men: immunologic profiles. (1983) (170)
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. (1999) (169)
Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons (2010) (164)
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy (2003) (151)
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. (1986) (151)
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. (1995) (137)
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. (1994) (136)
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. (1994) (136)
Combination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection (1993) (134)
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. (1994) (131)
Racial differences in end-stage renal disease rates in HIV infection versus diabetes. (2007) (130)
Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. (1985) (130)
Long-term clinical consequences of acute kidney injury in the HIV-infected. (2010) (129)
HIV-1 protease inhibitors (1997) (128)
Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. (1983) (123)
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies (2018) (115)
Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease. (1985) (115)
Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China. (2016) (112)
Treatment of Kaposi's sarcoma with interferon alfa‐2b (Intron® A) (1987) (106)
Fine-needle aspiration biopsy of patients with acquired immunodeficiency syndrome (AIDS): experience in an outpatient clinic. (1988) (102)
Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. (1983) (102)
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. (1985) (100)
Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. (1986) (97)
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. (1987) (92)
Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. (1987) (90)
Cryotherapy for Cutaneous Kaposi's Sarcoma (KS) Associated with Acquired Immune Deficiency Syndrome (AIDS): A Phase II Trial (1991) (89)
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. (1989) (89)
Human immunodeficiency virus hematology. (2003) (84)
Adherence communication: a qualitative analysis of physician-patient dialogue. (1999) (81)
Hematologic manifestations in homosexual men with Kaposi's sarcoma. (1984) (78)
The impact of anemia on quality of life in human immunodeficiency virus-infected patients. (2002) (75)
HIV and Premature Aging: A Field Still in Its Infancy (2010) (73)
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment (2009) (71)
Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. (1986) (71)
The impact of HIV on chronic kidney disease outcomes. (2007) (67)
Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group. (2000) (67)
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. (1990) (64)
Dronabinol effects on weight in patients with HIV infection. (1992) (63)
Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. (1985) (62)
Kaposi's sarcoma and the acquired immunodeficiency syndrome. (1986) (61)
Antiretroviral therapy for HIV infection: promises and problems. (1998) (60)
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. (1993) (60)
Lack of response to suramin in patients with AIDS and AIDS-related complex. (1987) (60)
Kaposi's sarcoma in AIDS. (1989) (58)
Serological characterization of HTLV-III infection in AIDS and related disorders. (1986) (57)
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers (2018) (57)
Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. (2007) (56)
Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. (1995) (52)
The pavia consensus statement. (2003) (51)
Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. (1988) (51)
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. (1986) (49)
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. (1989) (49)
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. (1991) (49)
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. (1984) (48)
Periodontal status of individuals in early stages of human immunodeficiency virus infection. (1991) (48)
Interferon-α2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma (1991) (48)
Kaposi sarcoma and lymphadenopathy syndrome: limitations of abdominal CT in acquired immunodeficiency syndrome. (1984) (46)
HIV therapy in 2003: consensus and controversy. (2003) (45)
Therapy of Kaposi's sarcoma in AIDS. (1984) (44)
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. (1979) (42)
Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome (1990) (42)
The AIDS Knowledge Base: A Textbook on HIV Disease from the University of California, San Francisco, and the San Francisco General Hospital (1994) (41)
The clinical spectrum of the acquired immunodeficiency syndrome: implications for comprehensive patient care. (1985) (41)
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. (1997) (41)
Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. (1988) (40)
Long-term survival in AIDS-related primary central nervous system lymphoma (2017) (40)
The role of chemotherapy for epidemic Kaposi's sarcoma. (1987) (40)
HIV quantification: clinical applications (1996) (40)
Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs (2015) (40)
Chemotherapy in advanced Kaposi's sarcoma. Implications for current cases in homosexual men. (1983) (39)
Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. (2011) (39)
Aids Clinical Review (1989) (38)
Recombinant interferon alpha in the treatment of acquired immune deficiency syndrome-related Kaposi's sarcoma. (1985) (38)
ALPHA INTERFERON THERAPY OF KAPOSRS SARCOMA IN AIDS (1984) (37)
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial. (1989) (36)
Advances in the medical management of patients with HIV-1 infection: an overview. (1999) (36)
Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004) (2007) (36)
Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals (2016) (35)
Therapy of acquired immune deficiency syndrome with recombinant interleukin-2. (1987) (35)
Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. (2015) (32)
SQUAMOUS CELL CARCINOMA IN SEXUAL PARTNER OF KAPOSI SARCOMA PATIENT (1982) (32)
Words matter: Discussing research towards an HIV cure in research and clinical contexts. (2014) (32)
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories. (1994) (31)
Zidovudine response relationships in early human immunodeficiency virus infection (1993) (30)
Anemia and HIV in the antiretroviral era: potential significance of testosterone. (2004) (29)
Does hepatitis C virus infection increase the risk of HIV disease progression? (2002) (29)
What can modeling tell us about the threat of antiviral drug resistance? (2002) (28)
HIGH‐GRADE NON‐HODGKIN'S LYMPHOMA IN PATIENTS WITH AIDS a (1984) (28)
Part-time careers in academic internal medicine: a report from the association of specialty professors part-time careers task force on behalf of the alliance for academic internal medicine. (2009) (28)
A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. (1992) (27)
Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials (1994) (27)
Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. (1986) (27)
Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial (2019) (27)
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex (1991) (26)
Improving the outcomes of care for patients with human immunodeficiency virus infection. (1996) (25)
Treatment of AIDS-related Kaposi's sarcoma. (1991) (25)
A methodology for the analysis of the preneoplastic antigen. (1984) (24)
Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy. (1988) (24)
Physicians' transmission prevention assessment and counseling practices with their HIV positive patients. (1999) (23)
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. (1992) (23)
Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States (2018) (22)
Clinical care and research in AIDS. (1985) (22)
Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA (2018) (20)
Crowdsourcing HIV Testing: A Pragmatic, Non-Inferiority Randomized Controlled Trial in China (2015) (20)
Baboon Bone-Marrow Xenotransplant in a Patient with Advanced HIV Disease: Case Report and 8-Year Follow-Up (2004) (19)
Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis (2017) (18)
HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel. (2017) (18)
FAILURE OF ISOTRETINOIN IN KAPOSI'S SARCOMA (1984) (17)
AIDS IN THE "GAY" AREAS OF SAN FRANCISCO (1983) (17)
Supporting the health care team in caring for patients with AIDS. (1989) (17)
Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics (2016) (17)
Incidence of the acquired immunodeficiency syndrome in San Francisco, 1980-1983. (1985) (16)
Perceptions of health care professionals and patients about the risk of HIV transmission through oral sex: a qualitative study. (1999) (16)
The Clinical Spectrum of the Acquired Immunodeficiency Syndrome: Implications for Comprehensive Patient Care (1986) (15)
Toward a definition of HIV expertise: a survey of experienced HIV physicians. (2001) (15)
The AIDS Clinical Trials Group (1990) (15)
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. (2007) (15)
Cerebral mass lesions in patients with AIDS. (1990) (14)
Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study (2020) (14)
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. (1991) (14)
The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine (1995) (14)
Health impact of human rights testimony: harming the most vulnerable? (2016) (14)
Epoetin Alfa for Treatment of Anemia in HIV-Infected Patients: Past, Present, and Future (2004) (13)
Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists? (2012) (13)
AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions. (1986) (12)
Caring for the patient with AIDS. An integrated approach. (1988) (12)
Educating primary care providers about HIV disease: multidisciplinary interactive mechanisms. (1994) (11)
Functional Assessment for Adults with Disabilities (2019) (11)
LYMPHADENOPATHY: ENDPOINT OR PRODROME? UPDATE OF A 24‐MONTH PROSPECTIVE STUDY (1984) (11)
HIV infection as a disease: the medical indications for early diagnosis. (1989) (10)
FAILURE (AND DANGER) OF MITOZANTRONE IN AIDS-RELATED KAPOSI'S SARCOMA (1985) (10)
Introduction: International perspectives on antiretroviral resistance (2001) (10)
Adherence, resistance, and timing: current issues in the use of new therapies. (2002) (10)
Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion (2016) (10)
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. (1986) (10)
Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the promoting access to care engagement (PACE) trial. (2019) (10)
Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex (1987) (10)
Providing clinical pharmacy services in an AIDS--oncology ambulatory-care clinic. (1988) (10)
Treatment of malignant disease in AIDS patients. (1988) (10)
Avian tumour virus interactions with chicken fibroblast membranes: partial characterization of initial attachment site activity. (1977) (9)
Antiviral Chemotherapy 4 (1996) (9)
Age as a predictor of progression in HIV infection (1996) (9)
AIDS clinical review 1995/1996. (1996) (9)
Increasing CD8+ T lymphocytes predict subsequent development of intraoral lesions among individuals in the early stages of infection by the human immunodeficiency virus. (1991) (9)
Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3. (1990) (8)
When and where to start: guidelines for the initiation of antiretroviral therapy. (2000) (8)
The management of early human immunodeficiency virus infection. (1991) (8)
Sande's HIV/AIDS Medicine: Medical Management of AIDS 2013: Second Edition (2012) (7)
The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. (2020) (7)
The impact of HIV research on health outcome and healthcare policy. (2011) (7)
Interferon and interleukin-2 therapy of Kaposi's sarcoma. (1985) (7)
Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. (1980) (7)
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. (2010) (6)
Case Reports of Psychiatric Disturbance in Patients with Acquired Immune-Deficiency Syndrome (1985) (6)
HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence. (2019) (6)
Hepatitis B virus (HBV) DNA in leucocytes in acquired immune deficiency syndrome (AIDS). (1985) (6)
HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship. (1994) (6)
Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria. (2021) (6)
Acquired immunodeficiency syndrome: The AIDS epidemic: continental drift (1984) (6)
International perspectives on antiretroviral resistance. Introduction. (2001) (6)
Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials. (1996) (6)
Augmented HIV-Specific Interferon-Gamma Responses, But Impaired Lymphoproliferation During Interruption of Antiretroviral Treatment Initiated in Primary HIV Infection (2011) (6)
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex (1991) (6)
An aggressive approach to HIV antiretroviral therapy. (1998) (5)
Exposure to hair dyes and polychlorinated dibenzo-p-dioxins in AIDS patients with Kaposi sarcoma: an epidemiological investigation. (1987) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
The Effect of Zidovudine on Erythrocyte Mean Corpuscular Volume in Asymptomatic HIV-Infected Individuals (1994) (5)
Prevalence of oral lesions in symptomatic and asymptomatic HIV patients. (1994) (5)
Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells (1985) (5)
AIDS clinical review 1993/1994. (1994) (5)
Treatment of AIDS and its attendant malignancies. (1989) (5)
Bringing the End in Sight: Consensus Regarding HIV Screening Strategies (2013) (5)
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study. (1985) (5)
Drug level monitoring in a double-blind multicenter trial: false-positive zidovudine measurements in AIDS clinical trials group protocol 019 (1991) (5)
A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. (1989) (5)
The Concorde trial (1993) (5)
Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG). (1994) (4)
AIDS: Etiology, Diagnosis, Treatment, and Prevention (1989) (4)
CEREBRAL MASS LESIONS IN PATIENTS WITH AIDS - ROLE AND TIMING OF CEREBRAL BIOPSY (1990) (4)
Navigating Emerging Challenges to Long‐Term HIV Therapy (2002) (4)
Phase II trial of 4'-epi-doxorubicin in metastatic melanoma. (1984) (4)
The UCSF AIDS Specimen Bank (1991) (4)
The need for additional options in the treatment of human immunodeficiency virus infection. (1995) (4)
Incidence of the acquired immunodeficiency syndrome in San Francisco. (1985) (4)
Aids clinical review 2000/2001. (2001) (4)
Isolated thrombocytopenia in homosexual men--longitudinal follow-up. (1985) (4)
How to Survive a Plague: The Next Great HIV/AIDS History. (2017) (4)
AIDS: variations on a theme of cellular immune deficiency (1987) (4)
Rationale for variations in clinical trial design in different HIV disease stages. (1990) (4)
Change in Condom Use in Populations Newly Aware of HIV Diagnosis in the United States and Canada: A Systematic Review and Meta-Analysis (2021) (3)
Treatment dilemmas in HIV infection. (1994) (3)
Perspectives on the use of antiretroviral drugs in the treatment of HIV infection. (1994) (3)
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate (2004) (3)
An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role. (1995) (3)
HIV Cure: The Target Is Clearer but Not Yet Close (2014) (3)
Management of the complications of human immunodeficiency virus infection. (1992) (3)
HIV Antigen Variability in ARC/AIDS (1991) (3)
Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study (2020) (3)
Opportunities and options for treatment research in resource-constrained settings. (2003) (3)
Sande's HIV/AIDS medicine, Medical management of AIDS 2012 (2012) (3)
Moving towards a uniform staging for human immunodeficiency virus-associated Kaposi's sarcoma. (1989) (3)
Counseling patients about HIV risk from oral sex (1997) (3)
Hepatic radiation (RT) plus multidrug intraarterial chemotherapy (IA-CT) for patients with liver tumors (1979) (3)
Malignant Diseases in Human Immunodeficiency Virus Infection (2010) (3)
Initiation of antiretroviral therapy in HIV infection: a review of interstudy consistencies. (1994) (2)
Recent advances in the medical management of early HIV disease (2007) (2)
Antiviral Chemotherapy 5 (1999) (2)
400 – Hematology and Oncology in Patients with Human Immunodeficiency Virus Infection (2012) (2)
Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease. (2002) (2)
The AIDS epidemic: continental drift. (1984) (2)
Antimicrobial Drug Development Efficiency and Surrogate Markers of Clinical Benefit. (2019) (2)
Protease inhibitors vindicated (1997) (2)
Initiating HIV Therapy (2004) (2)
The HIV epidemic: medical and social challenges. (1989) (2)
Epidemiology and the human immunodeficiency virus. Clinical effects of intravenous drug misuse. (1992) (2)
Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study (2020) (2)
CHAPTER 13 – Overview of Antiretroviral Therapy (2008) (2)
Class of antiretroviral drugs and anemia risk in the current treatment era (2019) (1)
From the Institute of Medicine. (1994) (1)
Routine Care and Psychosocial Support of the Patient With the Acquired Immunodeficiency Syndrome (1986) (1)
A Chronicle of Hope and Promise: The World As It Was, As It Is, and As It Can Be (2012) (1)
Who cares for AIDS? (2007) (1)
HIV expertise: a roundtable. (2001) (1)
The problem of Kaposi's sarcoma in AIDS. (1985) (1)
Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists? (2012) (1)
Disseminated Kaposi's sarcoma in male homosexuals. (1983) (1)
Health care utilization and HIV clinical outcomes following Affordable Care Act implementation in California: A longitudinal study (2020) (1)
Cohorts, Trials, and Evidence: Expanding Our Confidence in Guidelines for Antiretroviral Resistance Testing (2009) (1)
JAIDS: Transitions, Evolution, and Impact. (2017) (1)
AIDS : clinical review 1989 (1990) (1)
Chemotherapy for AIDS-associated Kaposi's sarcoma. (1991) (1)
Gene Therapy for HIV Infection (1994) (1)
Intermittent therapy. (1994) (1)
Zidovudine (AZT): costs and benefits. (1988) (1)
amfAR Institute for HIV Cure Research (2021) (1)
Optimal time to initiate anti-HIV therapy: clinical decisions without definitive data. (1992) (1)
Pharmacists involvement in clinical drug trials sponsored by the aids clinical trials group the role of investigational research pharmacists (1989) (1)
JAIDS and Human Retrovirology (1995) (1)
CHAPTER 12 – New HIV Drug Development (2007) (1)
Treatment of Human Immunodeficiency Virus in Adults—Reply (2012) (1)
Recommendations of the International AIDS Antiretroviral Treatment of Adult HIV Infection : 2008 (2008) (1)
Chapter 11 – Overview of antiretroviral therapy (2012) (1)
Do new protease inhibitors offer improved outcome expectations? Issues of PI adherence (2004) (1)
Is France Once Again Looking for a Scapegoat? (2021) (1)
Intestinal infection withMycobacterium avium in acquired immune deficiency syndrome (AIDS) (2005) (1)
The New York Case: Lessons Being Learned (2005) (1)
Book Review Impure Science: AIDS, activism, and the politics of knowledge (Medicine and Society. Vol. 7.) By Steven Epstein. 466 pp. Berkeley, University of California Press, 1996. $29.95. 0-520-20233-3 (1997) (1)
Sexual Practice Changes Post-HIV Diagnosis Among Men Who Have Sex with Men in the United States: A Systematic Review and Meta-analysis (2022) (0)
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control (2022) (0)
PP 4.11 – 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption (2022) (0)
The Resource Allocation Program at the University of California, San Francisco: Getting More from Intramural Funding Bucks. (2014) (0)
HIV post-treatment controllers have distinct immunological and virological features. (2023) (0)
Information , Inspiration and Advocacy for People Living with HIV / AIDS (2004) (0)
Letter from Paul Volberding, San Francisco General Hospital Medical Center to Harold Varmus (1985) (0)
HIVMA Award Presentation (2004) (0)
The Effect of Zidovudine on Patient Subgroups-Reply (1992) (0)
Interim monitoring in a treatment strategy trial with a composite primary endpoint. (2019) (0)
HIV/AIDS. Protease inhibitors vindicated. (1997) (0)
Controversies in initiating anti-retroviral therapy and in the use of combination therapies. (1996) (0)
HIVMA Emerging Leaders Award Presentations (2005) (0)
IAS-USA Board of Directors (2011) (0)
State-of-the-Art HIV Treatment (2004) (0)
An AIDS registry for epidemiology and clinical trials management (1986) (0)
Response: Epoetin Alfa for Treatment of Anemia in HIV-Infected Patients (2005) (0)
A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. (2017) (0)
What's Hot: Review of Recent HIV and ID Literature (2003) (0)
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Triple Combination Tablet (2006) (0)
Opening the Pathway to Current, Effective Antiretroviral Therapy (2007) (0)
Results of a Detailed Survey (2011) (0)
The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection (2020) (0)
The optimal management of patients with HIV infection: issues and advances (1999) (0)
Solving the mystery of JAIDS. (2013) (0)
The value of the CD4+ count of 500 cells/microliters. (1995) (0)
Building Networks for Global Clinical Research: The Basics (2015) (0)
Faculty Opinions recommendation of The survival benefits of AIDS treatment in the United States. (2006) (0)
Comprar Sande's HIV/ AIDS Medicine, 2nd Edition | Nelson Sewankambo | 9781455706952 | Saunders (2011) (0)
Attitudes and opinions toward HIV infection of 1,008 participants to the Vth International Conference on AIDS Montreal, 4-9 June 1989. (1990) (0)
Management of HIV Infection (2005) (0)
Immune Checkpoints: Convergence of Cancer Treatment & HIV Cure (2016) (0)
Comprar Global HIV/AIDS Medicine | Paul A. Volberding | 9781416028826 | Saunders (2007) (0)
Recombinant interleukin-2 therapy of acquired immune deficiency syndrome [abstract] (1986) (0)
96 Evaluation of predictors and impact of losses to follow-up in the domain of hiv infection (1997) (0)
Kaposi’s Sarcoma, B-cell Lymphoma and other AIDS-associated Tumours (1986) (0)
National Academies Consensus Report on Functional Assessment for Adults With Disabilities. (2019) (0)
What's Hot: Infectious Diseases and HIV (2005) (0)
Faculty Opinions recommendation of Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (2006) (0)
Solubilization of avian tumor virus receptor sites (1975) (0)
Antiviral chemotherapy 4 : new directions for clincal application and rersearch (2017) (0)
Highlights of the 2014 International AIDS Conference: update from down under. (2014) (0)
WHEN AND WHY SWITCH OR INTENSIFY (2003) (0)
CURRENT ISSUES IN ANTIRETROVIRAL THERAPY: A CASE-BASED APPROACH * (2006) (0)
Medicine and HIV. Interview by David Frankel. (1996) (0)
Sharing Experiences and Lessons: Medical Issues in Confronting the HIV Epidemic and COVID-19 (2020) (0)
Faculty Opinions recommendation of Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. (2006) (0)
Hematologic Manifestations in Homosexual Men With Kaposi’s Sarcoma (1984) (0)
Faculty Opinions recommendation of Elevated incidence of lung cancer among HIV-infected individuals. (2006) (0)
Early detection of HIV: implications for prevention research. Proceedings of a conference. (2000) (0)
Contributors (2012) (0)
Times Change: JAIDS Evolves (2013) (0)
The Value of the CD4+ Count of 500 cells/μl (2012) (0)
HIV therapy: taking advantage of progress (2018) (0)
Pharmacokinetics and Tumor Localization of DOX-SL (Stealth® Liposomal Doxorubicin) By Comparison with Adriamycin in Patients with AIDS and Kaposi Sarcoma (2018) (0)
Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design (1992) (0)
Faculty Opinions recommendation of The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial. (2007) (0)
Focus on Living: Portraits of Americans With HIV and AIDS (2003) (0)
AIDS: Modern Concepts and Therapeutic Challenges (1987) (0)
Crowdsourcing HIV Test Promotion Videos: A Non-Inferiority Randomized Controlled Trial in China **In Press at Clinical Infectious Diseases** (2018) (0)
Responding to a Pandemic: Lessons from the Early HIV Experience (2009) (0)
The Role of Prophylaxis in HIV Disease (1995) (0)
Intensive Care of Patients with the Acquired Immunodeficiency Syndrome. Outcome and Changing Patterns of Utilization (1987) (0)
Treatment Trends in Human Immunodeficiency Virus Disease, San Francisco, California, 16 July 1993 (1995) (0)
A clinical view: a trio of HIV specialists offer their take on HIV--then, now, and in the future. Interview by Heidi M Nass. (2012) (0)
Introduction (2001) (0)
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Ofﬁce of AIDS Research by the HIV and Aging Working Group the on and Aging (2018) (0)

This paper list is powered by the following services:

Other Resources About Paul Volberding

en.wikipedia.org

What Schools Are Affiliated With Paul Volberding?

Paul Volberding is affiliated with the following schools:

Image Attributions

Image Source for Paul Volberding